Sambial, Jeff P.
HRN: 22-93-12 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/17/2023
MUPIROCIN 2%, 15G (TUBE)
04/17/2023
04/24/2023
IV
Topical
Tid
Impetigo
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes